Li, Q., Zhang, H., Yun‐Liu, H., Zheng, P., & Xu, X. (2025). C1qtnf6 Expression as a Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma: Implications for Immune Infiltration and Tumor Progression. Wiley.
Chicago Style (17th ed.) CitationLi, Qincai, Hua Zhang, Hai Yun‐Liu, Peifeng Zheng, and Xiaogang Xu. C1qtnf6 Expression as a Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma: Implications for Immune Infiltration and Tumor Progression. Wiley, 2025.
MLA (9th ed.) CitationLi, Qincai, et al. C1qtnf6 Expression as a Prognostic Biomarker and Therapeutic Target in Lung Adenocarcinoma: Implications for Immune Infiltration and Tumor Progression. Wiley, 2025.
Warning: These citations may not always be 100% accurate.